BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27612165)

  • 1. Neuroprotective Effects of Sulphated Agaran from Marine Alga Gracilaria cornea in Rat 6-Hydroxydopamine Parkinson's Disease Model: Behavioural, Neurochemical and Transcriptional Alterations.
    Souza RB; Frota AF; Sousa RS; Cezario NA; Santos TB; Souza LM; Coura CO; Monteiro VS; Cristino Filho G; Vasconcelos SM; da Cunha RM; Aguiar LM; Benevides NM
    Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):159-170. PubMed ID: 27612165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
    Kopalli SR; Noh SJ; Koppula S; Suh YH
    Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Li H; Shi R; Ding F; Wang H; Han W; Ma F; Hu M; Ma CW; Huang Z
    Oxid Med Cell Longev; 2016; 2016():4856761. PubMed ID: 27885333
    [No Abstract]   [Full Text] [Related]  

  • 5. Eugenol and its association with levodopa in 6-hydroxydopamine-induced hemiparkinsonian rats: Behavioural and neurochemical alterations.
    Moreira Vasconcelos CF; da Cunha Ferreira NM; Hardy Lima Pontes N; de Sousa Dos Reis TD; Basto Souza R; Aragão Catunda Junior FE; Vasconcelos Aguiar LM; Maranguape Silva da Cunha R
    Basic Clin Pharmacol Toxicol; 2020 Oct; 127(4):287-302. PubMed ID: 32353201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.
    Roghani M; Niknam A; Jalali-Nadoushan MR; Kiasalari Z; Khalili M; Baluchnejadmojarad T
    Brain Res Bull; 2010 Jul; 82(5-6):279-83. PubMed ID: 20558255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease.
    Kumari N; Agrawal S; Kumari R; Sharma D; Luthra PM
    Neurosci Lett; 2018 May; 675():74-82. PubMed ID: 29567422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive and anti-inflammatory activities of sulphated polysaccharides from the red seaweed Gracilaria cornea.
    Coura CO; de Araújo IW; Vanderlei ES; Rodrigues JA; Quinderé AL; Fontes BP; de Queiroz IN; de Menezes DB; Bezerra MM; e Silva AA; Chaves HV; Jorge RJ; Evangelista JS; Benevides NM
    Basic Clin Pharmacol Toxicol; 2012 Apr; 110(4):335-41. PubMed ID: 21985563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schisandrin B shows neuroprotective effect in 6-OHDA-induced Parkinson's disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway.
    Ba Q; Cui C; Wen L; Feng S; Zhou J; Yang K
    Biomed Pharmacother; 2015 Oct; 75():165-72. PubMed ID: 26282218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of Althaea officinalis L. extract in 6-hydroxydopamine-induced hemi-Parkinsonism model: behavioral, biochemical and histochemical evidence.
    Rezaei M; Alirezaei M
    J Physiol Sci; 2014 May; 64(3):171-6. PubMed ID: 24464760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
    Kumar A; Sharma N; Gupta A; Kalonia H; Mishra J
    Brain Res; 2012 Aug; 1471():13-22. PubMed ID: 22789904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.
    Shi XR; Hong ZY; Liu HR; Zhang YC; Zhu YZ
    Neurochem Int; 2011 Jul; 58(8):851-60. PubMed ID: 21093517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymoquinone exerts neuroprotective effect in animal model of Parkinson's disease.
    Ebrahimi SS; Oryan S; Izadpanah E; Hassanzadeh K
    Toxicol Lett; 2017 Jul; 276():108-114. PubMed ID: 28526446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson's disease: Possible involvement of PI3K/ERβ signaling.
    Baluchnejadmojarad T; Jamali-Raeufy N; Zabihnejad S; Rabiee N; Roghani M
    Eur J Pharmacol; 2017 Apr; 801():72-78. PubMed ID: 28284752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemi-parkinsonian rats.
    Inden M; Kitamura Y; Kondo J; Hayashi K; Yanagida T; Takata K; Tsuchiya D; Yanagisawa D; Nishimura K; Taniguchi T; Shimohama S; Sugimoto H; Akaike A
    J Neurochem; 2005 Nov; 95(4):950-61. PubMed ID: 16135081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.
    Pinna A; Tronci E; Schintu N; Simola N; Volpini R; Pontis S; Cristalli G; Morelli M
    Neuropharmacology; 2010 Mar; 58(3):613-23. PubMed ID: 19951715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson's disease rat.
    Yang J; Song S; Li J; Liang T
    Pathol Res Pract; 2014 Jun; 210(6):357-62. PubMed ID: 24642369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.
    Jin F; Wu Q; Lu YF; Gong QH; Shi JS
    Eur J Pharmacol; 2008 Dec; 600(1-3):78-82. PubMed ID: 18940189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective action and mechanistic evaluation of protodioscin against rat model of Parkinson's disease.
    Wu J; Zhao YM; Deng ZK
    Pharmacol Rep; 2018 Feb; 70(1):139-145. PubMed ID: 29367101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
    Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
    Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.